Analyst Ratings for Opiant Pharma (OPNT) [Neutrals]
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
11/23/2022 | Northland | Carl Byrnes | Downgrade | Market Perform (Outperform) |
22.00 (N/A) |
20.09 (20.65) |
2.79% | Details |
11/22/2022 | Cantor Fitzgerald | Brandon Folkes | Downgrade | Neutral (Overweight) |
21.00 (N/A) |
20.07 (20.65) |
2.89% | Details |